Global Hemp Group Inc. announced the appointment of Dr. Herbert Fritsche to the Company's Advisory Board as its Chief Scientific Advisor. Dr. Fritsche is a world-renowned Clinical Chemist and former Professor of Laboratory Medicine and Chief of the Clinical Chemistry Section at the University of Texas MD Anderson Cancer Center for 41 years. Dr. Fritsche served as an invited consultant/advisor to the Food and Drug Administration, the National Cancer Institute, the Laboratory Practice Guidelines Committee for the National Academy of Clinical Biochemistry, the Editorial Board of six international scientific journals, and as a consultant to many major international diagnostic companies. Previously, he served on the Expert Panel for developing Tumor Marker Practice Guidelines
for the American Society of Clinical Oncology (ASCO) from its inception until his retirement from MD Anderson Cancer Center. Dr. Fritsche has served as President of the CLAS and various national committees for both the CLAS and AACC.
He is a Fellow of the National Academy of Clinical Biochemistry.